S. de Kimpe - Concepedia

Author

S. de Kimpe

ProQR Therapeutics (Netherlands)

Also Known As

De Kimpe, S, S. De Kimpe, S. de Kimpe, Sjef De Kimpe, Sjef de Kimpe, de Kimpe, S

Publications

775

Citations

H-Index

Concepts

All Affiliations

ProQR Therapeutics (Netherlands)Leiden University Medical Center Utrecht University University of California, Davis BioMarin (Netherlands)

About

S. de Kimpe is an author at ProQR Therapeutics (Netherlands) specializing in medicine, autoimmunity, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	106
2	Immunology	2	2	76
3	Cell Biology	1	1	20
4	Nephrology	1	1	56
5	Pathology	1	1	56

S. de Kimpe

Publications

708

Citations

H-Index

Page 1

	Year	Citations
Mechanism of Gram-positive Shock: Identification of Peptidoglycan and Lipoteichoic Acid Moieties Essential in the Induction of Nitric Oxide Synthase, Shock, and Multiple Organ Failure Ken M. Kengatharan, S. de Kimpe, Caroline D. Robson, The Journal of Experimental Medicine	1998	241
Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms Annemieke Aartsma‐Rus, Laura Van de Vliet, Marscha Hirschi, Molecular Therapy	2008	145
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model Hans Heemskerk, Christa de Winter, Petra van Kuik, Molecular Therapy	2010	137
Species-specific Inflammatory Responses as a Primary Component for the Development of Glomerular Lesions in Mice and Monkeys Following Chronic Administration of a Second-generation Antisense Oligonucleotide Kendall S. Frazier, Cécile Sobry, Victoria Derr, Toxicologic Pathology Glomerular DiseaseEndothelial Cell HypertrophyChronic AdministrationRenal PathologyImmunology	2013	56
Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy Craig M. McDonald, Brenda Wong, Kevin M. Flanigan, Annals of Clinical and Translational Neurology	2018	35
Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta Thi Danh Vuong, S. de Kimpe, Remmert de Roos, Kidney International Molecular PharmacologyMolecular PhysiologyMedicineVascular PharmacologyPhysiology	2001	30
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne Afrodite Lourbakos, Nabila Ado Ya’u, Peter de Bruijn, Scientific Reports	2017	29
Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP) A. Seda Yilmaz‐Elis, Annemieke Aartsma‐Rus, Peter A.C. ’t Hoen, Molecular Therapy — Nucleic Acids Il-1 SignalingSoluble δ9Il-1racp ProteinInflammatory Lung DiseaseImmunologyImmune Regulation	2013	20
Preclinical Studies on Intestinal Administration of Antisense Oligonucleotides as a Model for Oral Delivery for Treatment of Duchenne Muscular Dystrophy Maaike van Putten, Courtney S. Young, Sjoerd A.A. van den Berg, Molecular Therapy — Nucleic Acids	2014	15

Page 1